GenBio AI is pleased to announce that Dr. Emma Lundberg has officially joined the company as Co-Founder and Chief Scientific Advisor. In this role, Lundberg will lead development efforts across GenBio AI’s data strategy and scientific initiatives, helping to shape the future of AIDO (AI-Driven Digital Organism).
Advancing the Scientific Foundations of the AI-Driven Biology
Lundberg is internationally recognized for her research at the intersection of spatial proteomics, bioimaging, and artificial intelligence. She serves as Associate Professor of Bioengineering and Pathology at Stanford University and Professor at KTH Royal Institute of Technology in Sweden. She also directs the Cell Atlas of the Human Protein Atlas project, an ambitious global effort to map protein localization in human cells.
Her work has laid the foundation for building high-resolution virtual models of cells. These models enable simulations of biological systems that help researchers test hypotheses and study disease in silico, reducing reliance on traditional experimental approaches.
GenBio AI Co-Founder and Chief Scientific Advisor Emma Lundberg said:
“I’m thrilled to join GenBio AI in building the next generation of biology through AI. The opportunity to train multi-scale and multi-modal computational models, at a much larger scale than what can be done in academia, to simulate life at the cellular level is a dream for any scientist, and a crucial step toward transforming biomedical research.”
Scientific Leadership at a Turning Point
GenBio AI Co-Founder and Chief Scientist Eric Xing said:
“Emma’s visionary work in understanding cellular architecture through AI and imaging has redefined the boundaries of biomedical research. Her leadership will be instrumental as we push forward to develop the first virtual cell and virtual tissue using AI foundation models, toward our ultimate vision of an AI-driven digital organism that helps to phase out wet lab and animal testing.”
GenBio AI Co-Founder and Chief Technology Officer Le Song Said:
“Her passion for science, collaborative spirit, entrepreneurial mindset, and bold ideas make her an incredible addition to our founding team,”
Recognition and Impact
Lundberg’s contributions to science have been recognized with honors, including the Royal Microscopy Society’s Scientific Achievement Award and the Göran Gustafsson Prize. She has also been named among the top 10 under 40 future leaders in biopharma and omics.
She is widely known for promoting open science and involving the public in research through creative platforms such as gamified citizen science. She also advises several global organizations, including the Human Proteome Organization, Human Cell Atlas, UniProt, and the Chan Zuckerberg Initiative’s AI Virtual Cell project.
Looking Ahead
As we continue to expand our research, collaborations, and scientific applications, our mission remains focused on building AI-driven tools that contribute meaningfully to medicine, biotechnology, and human health. We’re excited to welcome Emma Lundberg to the GenBio AI team and look forward to working together to address the complex challenges at the intersection of AI and biology.
About GenBio AI
At GenBio AI, we are building the world’s first AI-driven Digital Organism (AIDO), a set of multiscale foundation models designed to simulate, predict, and program biology across all levels. With teams in Palo Alto, Abu Dhabi, and Paris, we are accelerating progress in drug design and biomedical research. Founded by world-renowned scientists from Carnegie Mellon University, Stanford University, the Mohamed bin Zayed University of Artificial Intelligence, and the Weizmann Institute of Science, the company is backed by leading investors committed to advancing the future of life sciences.
Join us in our mission to push the frontiers of AI-driven biology and strive to make a lasting impact on medicine, biotechnology, and human health. We are hiring across teams. Visit our Careers page to learn more and apply. Follow us on X, YouTube, and LinkedIn.
